New Slamf7-Targeted Car T-Cell Therapy

New SLAMF7-targeted CAR T-cell therapy

Multiple Myeloma Hub

New CAR T-cell targeting SLAMF7 shows efficacy against multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Immunotherapy of myeloma: BCMA/SLAMF7 CAR T-cells & BiTEs

VJHemOnc – Video Journal of Hematology & HemOnc

CARAMBA-1: a Phase I/IIa trial of autologous SLAMF7 CAR-Ts in multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

SLAMF7 as a target for multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Targeting SLAMF7 in myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

CARAMBA EU project: SLAMF7 CAR-T treatment of multiple myeloma

Myeloma Patients Europe

CAR T-cells in Multiple Myeloma

Dana-Farber Cancer Institute

CAR T-CELL THERAPY EXPLAINED|CANCER TREATMENT!

CAR T Cells in Multiple Myeloma

Dana-Farber Cancer Institute

Is CAR T-cell therapy being used to treat newly diagnosed multiple myeloma?

International Myeloma Foundation

What is CAR T-cell therapy?

International Myeloma Foundation

What are dual CAR-T cells? #myeloma

HealthTree University for Multiple Myeloma

Multiple Myeloma Patient Leads the Way as First CAR T-Cell Therapy Outpatient

Dana-Farber Cancer Institute

CAR T-cell Therapy: A game changer for #cancertreatment #immunotherapy #cancer

What is CAR T-Cell Therapy: How Does this CANCER Treatment Work?

The Patient Story

ide-cel; bb2121, a BCMA-targeted CAR T-cell therapy, in patients with RRMM: Initial KarMMa results

International Myeloma Foundation

Updates in CAR T Cell Therapies

National Cancer Institute

What Other Targets are Being Explored in CAR-T Cell Therapy? #myeloma

HealthTree University for Multiple Myeloma

The role of SLAMF7-positive, CD8-positive T-cells in therapeutic resistance in kidney cancer